What is Optomycin Eye Drops?
Optomycin Eye Drops belongs to the family of medicines called antibiotics. Optomycin Eye Drops ophthalmic preparations are used to treat infections of the eye. Optomycin Eye Drops may be given alone or with other medicines that are taken by mouth for eye infections.
Optomycin Eye Drops is available only with your doctor's prescription.
Optomycin Eye Drops indications
Optomycin Eye Drops should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. Bacteriological studies should be performed to determine the causative organisms and their sensitivity to Optomycin Eye Drops.
Optomycin Eye Drops, 1% (Optomycin Eye Drops Ophthalmic Ointment, USP) is indicated for the treatment of surface ocular infections involving the conjunctiva and/or cornea caused by Optomycin Eye Drops-susceptible organisms.
The particular antiinfective drug in this product is active against the following common bacterial eye pathogens:
Staphylococcus aureus
Streptococcus, including Streptococcus pneumoniae
Escherichia coli
Haemophilus influenzae
Klebsiella/Enterobacter species
Moraxella lucunata
(Morax-Axenfeld bacillus)
Neisseria species
This product does not provide adequate coverage against:
Pseudomonas aeruginosa
Serratia marcescens
How should I use Optomycin Eye Drops?
Use Optomycin Eye Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Optomycin Eye Drops is usually administered as an injection at your doctor's office, hospital, or clinic. If you are using Optomycin Eye Drops at home, carefully follow the injection procedures taught to you by your health care provider.
- If Optomycin Eye Drops contains particles or is discolored, or if the vial is cracked or damaged in any way, do not use it.
- To clear up your infection completely, continue using Optomycin Eye Drops for the full course of treatment even if you feel better in a few days.
- Keep this product, as well as syringes and needles, out of the reach of children. Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor or pharmacist to explain local regulations for proper disposal.
- If you miss a dose of Optomycin Eye Drops, use it as soon as possible. Then use your doses at evenly spaced times as directed by your doctor. Do not use 2 doses at once.
Ask your health care provider any questions you may have about how to use Optomycin Eye Drops.
Uses of Optomycin Eye Drops in details
Use: Labeled Indications
Serious infections: Treatment of serious infections, including cystic fibrosis exacerbations, bacterial meningitis, and bacteremia, caused by Chlamydiaceae, Haemophilus influenzae, Rickettsia, Salmonella spp. (acute infections), and other organisms when other less toxic agents are ineffective or contraindicated.
Guideline recommendations: Optomycin Eye Drops may be considered for use as an alternative agent to doxycycline in the treatment of tickborne rickettsial diseases (eg, Rocky Mountain spotted fever [RMSF]); however, epidemiologic studies suggest that Optomycin Eye Drops-treated patients with RMSF are at a higher risk of death compared to tetracycline-treated patients. In addition, Optomycin Eye Drops is not effective in the treatment of human ehrlichiosis or anaplasmosis, therefore, use with caution in the empiric treatment of tickborne rickettsial diseases (CDC [Biggs 2016]).
Optomycin Eye Drops description
Each 100 g contains Chloramphenicol 1 g.
Optomycin Eye Drops dosage
Optomycin Eye Drops Dosage
Generic name: Optomycin Eye Drops
Dosage form: ophthalmic ointment
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
A small amount of ointment placed in the lower conjunctival sac every three hours, or more frequently if deemed advisable by the prescribing physician. Administration should be continued day and night the first 48 hours, after which the interval between applications may be increased. Treatment should be continued for at least 48 hours after the eye appears normal.
More about Chloromycetin Ophthalmic (Optomycin Eye Drops ophthalmic)
- Side Effects
- Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews · Be the first to review/rate this drug
Consumer resources
- Other brands: Ocu-Chlor, Chloroptic, AK-Chlor
Professional resources
- Optomycin Eye Drops (FDA)
Other formulations
- Chloromycetin
- Chloromycetin Sodium Succinate
Optomycin Eye Drops interactions
Alcohol (Ethyl): Optomycin Eye Drops (Systemic) may enhance the adverse/toxic effect of Alcohol (Ethyl). Monitor therapy
Barbiturates: Optomycin Eye Drops (Systemic) may decrease the metabolism of Barbiturates. Barbiturates may increase the metabolism of Optomycin Eye Drops (Systemic). Monitor therapy
BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). Avoid combination
BCG (Intravesical): Myelosuppressive Agents may diminish the therapeutic effect of BCG (Intravesical). Avoid combination
BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). Monitor therapy
Carbocisteine: Optomycin Eye Drops (Systemic) may enhance the adverse/toxic effect of Carbocisteine. Specifically, Optomycin Eye Drops may enhance adverse effects of alcohol that is present in liquid formulations of carbocisteine-containing products. Monitor therapy
CefTAZidime: Optomycin Eye Drops (Systemic) may diminish the therapeutic effect of CefTAZidime. Management: Consider using a different combination of antimicrobials, especially if bactericidal activity is desired. If these agents are combined, monitor for reduced antimicrobial effectiveness and/or therapeutic failure. Consider therapy modification
Optomycin Eye Drops (Ophthalmic): May enhance the adverse/toxic effect of Myelosuppressive Agents. Monitor therapy
Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine. Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics. Avoid combination
Cladribine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Avoid combination
CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for neutropenia may be increased. Monitor therapy
CycloSPORINE (Systemic): Optomycin Eye Drops (Systemic) may increase the serum concentration of CycloSPORINE (Systemic). Management: Cyclosporine dose reductions will likely be required with initiation of concurrent Optomycin Eye Drops. Monitor cyclosporine concentrations and response closely following initiation and/or discontinuation of Optomycin Eye Drops. Consider therapy modification
Deferiprone: Myelosuppressive Agents may enhance the neutropenic effect of Deferiprone. Management: Avoid the concomitant use of deferiprone and myelosuppressive agents whenever possible. If this combination cannot be avoided, monitor the absolute neutrophil count more closely. Consider therapy modification
Dipyrone: May enhance the adverse/toxic effect of Myelosuppressive Agents. Specifically, the risk for agranulocytosis and pancytopenia may be increased Avoid combination
Fosphenytoin: May decrease the serum concentration of Optomycin Eye Drops (Systemic). Fosphenytoin may increase the serum concentration of Optomycin Eye Drops (Systemic). Optomycin Eye Drops (Systemic) may increase the serum concentration of Fosphenytoin. Monitor therapy
Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. Monitor therapy
Mesalamine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Monitor therapy
Phenytoin: May decrease the serum concentration of Optomycin Eye Drops (Systemic). Phenytoin may increase the serum concentration of Optomycin Eye Drops (Systemic). Optomycin Eye Drops (Systemic) may increase the serum concentration of Phenytoin. Monitor therapy
Promazine: May enhance the myelosuppressive effect of Myelosuppressive Agents. Monitor therapy
RifAMPin: May increase the metabolism of Optomycin Eye Drops (Systemic). Monitor therapy
Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate. Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic. Consider therapy modification
Sulfonylureas: Optomycin Eye Drops (Systemic) may decrease the metabolism of Sulfonylureas. Monitor therapy
Tacrolimus (Systemic): Optomycin Eye Drops (Systemic) may increase the serum concentration of Tacrolimus (Systemic). Management: Tacrolimus dose reductions will likely be required with initiation of concurrent Optomycin Eye Drops. Monitor tacrolimus concentrations and response closely following initiation and/or discontinuation of Optomycin Eye Drops. Consider therapy modification
Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected. Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents. Use of this vaccine should be postponed until at least 3 days after cessation of antibacterial agents. Consider therapy modification
Vitamin B12: Optomycin Eye Drops (Systemic) may diminish the therapeutic effect of Vitamin B12. Monitor therapy
Vitamin K Antagonists (eg, warfarin): Optomycin Eye Drops (Systemic) may enhance the anticoagulant effect of Vitamin K Antagonists. Optomycin Eye Drops (Systemic) may increase the serum concentration of Vitamin K Antagonists. Monitor therapy
Voriconazole: Optomycin Eye Drops (Systemic) may increase the serum concentration of Voriconazole. Monitor therapy
Optomycin Eye Drops side effects
See also:
What are the possible side effects of Optomycin Eye Drops?
Applies to Optomycin Eye Drops: capsule, powder for solution, suspension
In addition to its needed effects, some unwanted effects may be caused by Optomycin Eye Drops (the active ingredient contained in Optomycin Eye Drops). In the event that any of these side effects do occur, they may require medical attention.
Stop taking Optomycin Eye Drops and get emergency help immediately if any of the following effects occur:
Rare - in babies only
- Bloated stomach
- drowsiness
- gray skin color
- low body temperature
- uneven breathing
- unresponsiveness
Major Side Effects
You should check with your doctor immediately if any of these side effects occur when taking Optomycin Eye Drops:
Less common:
- Pale skin
- sore throat and fever
- unusual bleeding or bruising
- unusual tiredness or weakness (the above side effects may also occur up to weeks or months after you Stop taking Optomycin Eye Drops)
- Confusion, delirium, or headache
- eye pain, blurred vision, or loss of vision
- numbness, tingling, burning pain, or weakness in the hands or feet
- skin rash, fever, or difficulty in breathing
Minor Side Effects
Some of the side effects that can occur with Optomycin Eye Drops may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
Less common:
- Diarrhea
- nausea or vomiting
Optomycin Eye Drops contraindications
See also:
What is the most important information I should know about Optomycin Eye Drops?
Optomycin Eye Drops Lotion is contraindicated for premature neonates because their skin may be more permeable than full term infants and their liver enzymes may not be sufficiently developed. It is also contraindicated for patients with Norwegian (crusted) scabies due to possible increased absorption. It is also contraindicated for patients with known seizure disorders and for individuals with a known sensitivity to the product or any of its components.
Active ingredient matches for Optomycin Eye Drops:
Chloramphenicol in Philippines.
| Unit description / dosage (Manufacturer) | Price, USD |
| Optomycin Eye Drops 0.5 % x 10 mL | $ 3.58 |
List of Optomycin Eye Drops substitutes (brand and generic names): | |
| Optomycin Ear Drops (Philippines) | |
| Optomycin Ear Drops 5 % x 10 mL | $ 3.58 |
| Optrex Bacterial Conjunctivitis 1% (United Kingdom) | |
| Optrex Infected Eye (United Kingdom) | |
| Optrex Infected Eyes (United Kingdom) | |
| Orbachlor 0.5% (Peru) | |
| Orichlor | |
| Orichlor 30 ml Syrup (Orison Pharmaceuticals) | $ 0.03 |
| Osochlor | |
| Osochlor 500 mg Tablet (Osho Pharma Pvt.Ltd.) | $ 0.05 |
| Osochlor 250 mg Tablet (Osho Pharma Pvt.Ltd.) | $ 0.03 |
| Otachron | |
| Otiden (India) | |
| Otiden Chloramphenicol 5 %, Beclomethasone dipropionate0.025 %, Clotrimazole 1 %, Lignocaine 2 %. EAR-DPS / 10ml (BMW Pharmaco India Pvt Ltd) | $ 0.36 |
| 10ml (BMW Pharmaco India Pvt Ltd) | $ 0.36 |
| Otiden 10 ml Drop (BMW Pharmaco India Pvt Ltd) | $ 0.04 |
| Otiden Chloramphenicol 5 %, beclomethasone dipropionate0.025 %, clotrimazole 1 %, lignocaine hydrochloride 2 %. EAR DPS / 10ml (BMW Pharmaco India Pvt Ltd) | $ 0.46 |
| OTIDEN ear drops 10ml (BMW Pharmaco India Pvt Ltd) | $ 0.46 |
| Otophen | |
| Otophenicol (Ethiopia) | |
| Otophenicol 5% (Egypt) | |
| Otosym (India) | |
| Otosym Chloramphenicol 5 % w/v, Beclomethasone dipropionate0.025 % w/v, Clotrimazole 1 %w/v, Lignocaine hydrochloride2 % w/v. EAR-DPS / 5ml (Symbiosis Labs (P) Ltd.) | $ 0.36 |
| 5ml (Symbiosis Labs (P) Ltd.) | $ 0.36 |
| Otosym Ear 5 ml Drop (Symbiosis Labs (P) Ltd.) | $ 0.07 |
| Otosym Chloramphenicol 5 % w/v, beclomethasone dipropionate0.025 % w/v, clotrimazole 1 %w/v, lignocaine hydrochloride2 % w/v. EAR DPS / 5ml (Symbiosis Labs (P) Ltd.) | $ 0.36 |
| OTOSYM ear drops 5ml (Symbiosis Labs (P) Ltd.) | $ 0.36 |
| Ototic | |
| Ototic Ear 5 ml Drop (Zest Pharma) | $ 0.43 |
| Owadziak | |
| Palcol (Mexico) | |
| Palmiclor (Mexico) | |
| Palmicol (Indonesia) | |
| Palmicol 250 mg x 10 x 10's (Cheplapharm) | |
| Palmicol 125 mg/5 mL x 60 mL (Cheplapharm) | |
| Palmifer (Mexico) | |
| Palmisol (Mexico) | |
| Palmitato de Chloromycetin (Mexico) | |
| Suspension; Oral; Chloramphenicol Palmitate 312.5 mg / ml | |
| Pantofenicol (Spain) | |
| Pantovernil | |
| Paraxin (Colombia, Ecuador, Ethiopia, India) | |
| Capsule; Oral; Chloramphenicol; Chloramphenicol Palmitate (AHPL) | |
| Injectable; Injection; Chloramphenicol; Chloramphenicol Palmitate (AHPL) | |
| Drops; Oral; Chloramphenicol; Chloramphenicol Palmitate (AHPL) | |
| Ointment; Topical; Chloramphenicol; Chloramphenicol Palmitate (AHPL) | |
| PARAXIN Capsule/ Tablet / 250mg / 10 units (AHPL) | $ 0.55 |
| PARAXIN Capsule/ Tablet / 500mg / 6 units (AHPL) | $ 0.63 |
| Paraxin 250mg SC-TAB / 10 (AHPL) | $ 0.55 |
| Paraxin 250mg CAP / 10 (AHPL) | $ 0.55 |
| Paraxin 500mg CAP / 6 (AHPL) | $ 0.63 |
See 1906 substitutes for Optomycin Eye Drops | |
References
- DailyMed. "CHLORAMPHENICOL: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "chloramphenicol". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "chloramphenicol". http://www.drugbank.ca/drugs/DB00446 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Optomycin Eye Drops are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Optomycin Eye Drops. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Optomycin Eye Drops drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 1 | 100.0% | |
Consumer reported price estimates
No survey data has been collected yet4 consumers reported time for results
To what extent do I have to use Optomycin Eye Drops before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 3 days and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Optomycin Eye Drops. To get the time effectiveness of using Optomycin Eye Drops drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 3 days | 1 | 25.0% | |
| 1 day | 1 | 25.0% | |
| 1 week | 1 | 25.0% | |
| 1 month | 1 | 25.0% | |
14 consumers reported age
| Users | % | ||
|---|---|---|---|
| 6-15 | 4 | 28.6% | |
| 1-5 | 3 | 21.4% | |
| < 1 | 3 | 21.4% | |
| 30-45 | 2 | 14.3% | |
| > 60 | 1 | 7.1% | |
| 16-29 | 1 | 7.1% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
